Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study

Author
Sezer, A.
Celik, I.
Sendur, M. A. N.
Kilickap, S.
Akbulut, H.
Urun, Y.
Abali, H.
Turna, H.
Esin, E.
Sedef, A. M.
Alkan, A.
Oksuzoglu, B.
Ozdemir, N. Y.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/79123
https://doi.org/10.1016/s0959-8049(16)31872-x
Collections